Compliance Rate
Compliance Rate
0.0%
Compliant submissions
0
Incompliant submissions
1
Total trials
1
My Organizations' Clinical Trials
Showing 1175 of 3033 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 04/30/10
Due: 04/30/11
Phase: N/A
Priority: Normal
Start: 08/08/18
End: 09/02/19
Due: 09/02/20
Phase: N/A
Priority: Normal
Start: 10/31/16
End: 09/07/23
Due: 09/07/24
Phase: N/A
Priority: Normal
Start: 07/31/07
End: 04/30/08
Due: 04/30/09
Phase: N/A
Priority: Normal
Start: 06/30/04
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 09/24/18
End: 01/17/19
Due: 01/17/20
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 03/14/22
End: 04/05/22
Due: 04/05/23
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 07/14/22
End: 06/29/23
Due: 06/29/24
Phase: N/A
Priority: Normal
Start: 03/31/03
End: 03/31/08
Due: 03/31/09
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 03/27/19
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 09/28/23
End: 07/15/27
Due: 07/15/28
Phase: N/A
Priority: Normal
Start: 06/27/18
End: 01/31/27
Due: 01/31/28
Phase: N/A
Priority: Normal
Start: 11/13/20
End: 07/30/25
Due: 07/30/26
Phase: N/A
Priority: Normal
Start: 01/12/22
End: 09/13/22
Due: 09/13/23
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 02/28/11
Due: 02/28/12
Phase: N/A
Priority: Normal
Start: 06/27/19
End: 05/31/30
Due: 05/31/31
Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients
Phase: N/A
Priority: Normal
Start: 07/06/22
End: 06/30/28
Due: 06/30/29
Phase: N/A
Priority: Normal
Start: 10/30/20
End: 08/18/21
Due: 08/18/22
Phase: N/A
Priority: Normal
Start: 03/15/19
End: 04/05/23
Due: 04/05/24
Phase: N/A
Priority: Normal
Start: 04/30/07
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 03/31/06
End: 06/30/07
Due: 06/30/08
Phase: N/A
Priority: Normal
Start: 07/20/21
End: 07/20/21
Due: 07/20/22